Graphex Group Terminates U.S. ADS Programme, Citing Limited Volume and Hong Kong Liquidity

Bulletin Express
04/17

Graphex Group Limited has initiated the voluntary termination of its sponsored American Depositary Shares (ADS) programme in the United States. The ADSs—trading under the symbol “GRFXY” on the OTC Expert Market and each representing 20 ordinary shares—will be delisted on 14 July 2026 at 5:00 p.m. U.S. Eastern Time, the formal Termination Date set by depositary The Bank of New York Mellon.

Key details

• Timeline and process: The Company instructed the Depositary on 10 April 2026 to end the deposit agreement. A termination notice was disseminated on 16 April 2026, triggering a minimum 90-day period before the 14 July 2026 termination. Until that date, ADS holders may convert their ADSs into ordinary shares listed on The Stock Exchange of Hong Kong Limited (HKSE). Afterward, any remaining ADSs will be sold by the Depositary, with net proceeds distributed to holders in line with the agreement.

• Background of the ADS programme: Graphex launched its ADSs in October 2020 on the OTCQX market. In August 2022, the Company completed a public offering of 5.40 million ADSs and subsequently traded on NYSE American LLC. Following a 5-for-1 share consolidation on 26 March 2025, NYSE American suspended ADS trading on 15 May 2025 and delisted the securities on 23 May 2025. The ADSs then moved to the OTC Expert Market.

• Reasons for termination: Management cited the small proportion of ordinary shares represented by ADSs, relatively low ADS trading volume versus Hong Kong turnover, and confidence that the Hong Kong listing can meet future fundraising and global investor access needs.

Post-termination positioning

Graphex Group will maintain its ordinary-share listing on the HKSE (stock code 06128) and will continue to publish material English-language disclosures on its website. The Board emphasised its commitment to protecting investor interests throughout the transition.

Shareholders and potential investors are advised to exercise due care when trading the Company’s securities.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10